Beating Cardiovascular Disease and Diabetes

utilizing advanced Biomarkers


  • Oncology
  • Endocrinology
  • Pain Management
  • Rheumatology
  • Neurology

Natural medicine is my passion. As a writer, lecturer, practitioner, radio host, manager, trainer, and even patient I do my best to advance the field of integrative/natural/functional medicine and wellness. I've been able to manage my Crohn's disease virtually flawlessly for over a decade, and help many others with gastrointestinal issues. I keep abreast of the latest information, and get to rub shoulders with other thought leaders in the field. One current area of focus is to showcase the many benefits of this field by reducing healthcare costs on a corporate level. 

Nicotinamide Riboside (NR) is a novel compound with multiple applications.

NR is currently the "hot topic", with feverish research ongoing globally at notables such as Harvard, MIT, Cornell, and a concussion trial at Mayo Clinic. NR is the most efficient way to increase NAD systemically. NR is a part of the NAD salvage pathway, and has numerous advantages over all other niacin/NADH options.

In addition to the ATP enhancing ability which you can grasp from a vague recollection of college biochemistry, NAD plays an enormous role in many other stress responses in the human body. NAD is consumed by a number of enzymes, to include sirtuins (think resveratrol and "anti'aging") and PARPs, which repair damaged DNA.

This presentation will explain the benefits of NAD in; 

  • metabolism (to include HDL, LDL, triglycerides, at the pancreas, and more)
  • neurology (and how damaged neurons utilize NAD for survivability) 
  • de-acetylation (if you think methylation is important, you'll find the data  behind  cetylation/deacetylation very valuable)
  • and other applications in "anti-aging, sports performance, and DNA repair.  

Advancing the field of personalized

medicine in neuropsychiatry

Breakthrough approaches to address

 Gluten Exposure and Sensitivities

September 2015

Heal and Reduce Pain 

February 2016

Over a quarter of U.S. adults are diagnosed with one or more mental disorders and by 2020, major depressive illness will be the leading cause of disability in the world for women and children.
Individualized medicine has the potential to both increase treatment effectiveness and lower costs across a range of medical specialties.  Applying this technology to mental health problems provides a more rational and personal approach to treatment.
Genomind offers The Genecept Assay, a simple to use saliva-based test that offers a proprietary panel of 10 genes that allow you to personalize your patients' mental health treatment.
Dr. Lombard will discuss each gene and provide both supplement and pharmaceutical options to customize your approach to care.

Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. At our core is a belief in the combined power of a caring clinician and scientific research. We are founded by a psychiatrist, Ronald I. Dozoretz, MD, and a neurologist, Jay Lombard, DO, who share a common goal of helping the most difficult to treat patients. We are committed to bringing science to psychiatry and to creating new innovations that will help clinicians improve their patients' lives. Thought leaders from the world's most prestigious institutions are on our Scientific Advisory Board. These members are on the forefront of psychiatric and neurologic research. The Advisory Board includes Scott T. Aaronson, MD; P. Murali Doraiswamy, MD; Maurizio Fava, MD; Anil Malhotra, MD; Roy H. Perlis, MD MSc; Stephen M. Stahl, MD, PhD, and Rudolph E. Tanzi,

Dr. Guy Daniels

Dr. John Osbourne 

 Dr. Tom O'bryan

Come join us for an informative discussion

that will provide you with the tools you need

to protect your practice and your patients! ​

Nicotinamide Riboside 

"I promise, you will walk away from this presentation 
having learned a great deal of new information, 
which is highly applicable in your practices"

Stephen Noseworthy

Gene mapping for Neuropsychiatry  

 A novel compound in the treatment of metabolic
syndrome, and other stress responses.

January 2016

Clinical Associate Professor of Pharmacotherapy

Gluten Exposure and Sensitivities  

Beating Cardiovascular Disease and Diabetes

utilizing advanced Biomarkers

The Neuroendocrine Immunology of Exercise.

April 2016

August 2015


  • The impact of exercise on brain-derived neurotrophic factor, brain health, and the positive and negative endocrine shifts that may occur
  • Information on immunometabolism, including the role the immune system plays in metabolism and weight gain
  • When to use and not use exercise as a health strategy for clients

This seminar, developed by Dr. Datis Kharrazian, will examine the physiological changes that take place in the endocrine, immune, nervous, and vascular systems with both healthy and overtraining syndrome.

The presentation will also analyze the impacts of exercise on diabetes, dementia, autoimmunity, and depression. The immunometabolic mechanisms-such as environment, infection, and food intolerances- and the role they play in individuals who have the inability to lose weight will also be discussed.

Dr. Noseworthy earned his designation as a board-certified chiropractic neurologist through the Carrick Institute for Graduate Studies and has continued to apply neurological principles to clinical practice. He was a practicing physician and the clinical director of a multidisciplinary clinic in south Florida that included a team of eight healthcare professionals spanning chiropractic, allopathic, naturopathic, and Oriental medicines.

Y.W. Francis Lam, Pharm D.

Matt Debow



Dr. Osborne is focused on preventive cardiology and on noninvasive techniques, and he is the only physician board certified in Cardiology and Internal Medicine, Lipidology, Clinical Hypertension, Cardiac CT Angiography, Echocardiography and Nuclear Cardiology.

His clinical interests include preventive cardiology, metabolic syndrome, hypertension, congestive heart failure, cholesterol disorders, and cardiovascular genetics.

He is the founder and director of State of the Heart Cardiology, and Chief of Cardiology at Dallas Medical Center. He obtained his B.S. with honors from Penn State University, his M.D. magna cum laude from Jefferson Medical College, and his Ph.D. in cardiovascular physiology from Thomas Jefferson University. After graduation, he continued his post-doctoral at Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts where he completed his internship, Residency and Research Residency in Internal Medicine and a Fellowship in Cardiovascular Disease.

While at Harvard, Dr. Osborne published many articles on atherosclerosis, vascular biology, and molecular genetics.

Matt DeBow is an author, inventor, public speaker and innovative leader.
Much of his career has involved marketing, business development and
personnel management. Most recently he has moved into medical device
design and manufacturing. With his recent release of LuxWaves
photobiological light therapy devices, and NitroBio food base nitric oxide
activation supplements.” In 2001 DeBow produced a documentary, “Healing
with Light: Advanced Medical Technology, and in 2012 released his book,
“LIGHT: Health Benefits & Medical Applications.” He has several articles
and video clips on website, acquired in
interviews with experts from; Harvard, Berkeley, Stanford, UT, NASA, DOD,

His presentation covers a spectrum of information pertaining to light and
its effects on biology. He unearthed studies on artificial light, sunlight
and the advances in medical technology. He points out how light is the
next evolutionary step in medicine, which is extremely disruptive to the
established allopathic medical system. Light is now being used to
accelerate healing, remove pathogens from the blood, destroy cancer cells,
control brain neurons and used to revitalize skin and eliminate acne in
the cosmetic industry. Also presented is an effective medical industry
model which is currently the fastest growing health care system in the

 Dr. Jay Lombard D.O.

Gluten Sensitivity and Celiac Disease are at either end of a complex conundrum in clinical practice. The protocols for practitioner and patient have been seen as a one-point strategy-removal of the offending environmental agent-gluten. Unfortunately, very few patients experience vibrant health on a gluten-free diet.
Dr. Tom O'Bryan DC, CCN, DACBN is an internationally recognized speaker and workshop leader specializing in the complications of Non-Celiac Gluten Sensitivity, Celiac Disease, and Autoimmune Disease as they occur inside and outside of the intestines. He is the founder of the website theDr. He is the visionary behind the paradigm-shifting 'The Gluten Summit - A Grain of Truth', bringing together 29 of the world's experts on the Gluten connection to diseases, disorders, a wide-range of symptoms and ages. 

Austin Functional Medicine

Taking the guesswork out of prescribing medication

Advanced Biomarkers

November 2015

Light Therapy

October 2015

Pharmacogenomics is the study of how genes affect a person’s response to drugs.

This field of science combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.

Many drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It can be difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects.

Adverse drug reactions are a significant cause of hospitalizations and deaths in the United States. Pharmacogenomic testing is currently a "hot topic" around the globe.

Areas of medicine covered include:

  • Cardiology
  • Urology
  • Psychiatry
  • Infectious Disease
  • Gastroenterology